Enhancing the epidemiological surveillance of SARS-CoV-2 using Sanger sequencing to identify circulating variants and recombinants

Thaís Silva,Eneida Oliveira,Alana Oliveira,André Menezes,Wander de Jesus Jeremias,Rafaella Fq Grenfell,Rubens Lima do Monte-Neto,Marcelo A Pascoal-Xavier,Marco A Campos,Gabriel Fernandes,Pedro Alves

DOI: https://doi.org/10.1007/s42770-024-01387-x

2024-05-28

Brazilian Journal of Microbiology

Abstract:Since the emergence of SARS-CoV-2 in December 2019, more than 12,000 mutations in the virus have been identified. These could cause changes in viral characteristics and directly impact global public health. The emergence of variants is a great concern due to the chance of increased transmissibility and infectivity. Sequencing for surveillance and monitoring circulating strains is extremely necessary as the early identification of new variants allows public health agencies to make faster and more effective decisions to contain the spread of the virus. In the present study, we identified circulating variants in samples collected in Belo Horizonte, Brazil, and detected a recombinant lineage using the Sanger method. The identification of lineages was done through gene amplification of SARS-CoV-2 by Reverse Transcription-Polymerase Chain Reaction (RT-PCR). By using these specific fragments, we were able to differentiate one variant of interest and five circulating variants of concern. We were also able to detect recombinants. Randomly selected samples were sequenced by either Sanger or Next Generation Sequencing (NGS). Our findings validate the effectiveness of Sanger sequencing as a powerful tool for monitoring variants. It is easy to perform and allows the analysis of a larger number of samples in countries that cannot afford NGS.

microbiology

What problem does this paper attempt to address?

The problem this paper attempts to address is enhancing epidemiological surveillance of SARS-CoV-2 by using Sanger sequencing to identify circulating viral variants and recombinants. Specifically, the study aims to:

1. **Monitor and identify SARS-CoV-2 variants**: Identify circulating SARS-CoV-2 variants, including Variants of Concern (VOC) and Variants of Interest (VOI), by amplifying and sequencing genes from samples collected in Belo Horizonte, Brazil.

2. **Detect recombinants**: Detect SARS-CoV-2 recombinants, particularly the XAG recombinant, using specific primer combinations.

3. **Validate the effectiveness of Sanger sequencing**: Evaluate Sanger sequencing as an economical, rapid, and effective tool for monitoring SARS-CoV-2 variants, especially in countries and regions that cannot afford Next Generation Sequencing (NGS) technology.

4. **Compare Sanger sequencing with NGS**: Compare the effectiveness and cost-efficiency of the two methods in identifying SARS-CoV-2 variants by randomly selecting some samples for NGS sequencing.

Overall, the study hopes to provide timely and accurate data to public health agencies through these methods, enabling faster decision-making and effective control of virus spread.